Newsroom

**Nixtla awarded in Fast Company’s Fourth Annual List of the Next Big Things in Tech**

Nixtla is the first to do for time series models what OpenAI has done for language models – making them accessible to anyone. Any organization performing forecasting or anomaly detection can benefit from a time series model. Learn more about the company and this exciting development here.

Harmonic Announces Series A Funding Round To Accelerate Development of Mathematical Superintelligence

Harmonic is building the world's most advanced mathematical reasoning engine. Its state of the art technology and interdisciplinary approach aim to create AI solutions that outperform human abilities in critical problem-solving areas. Learn more about the company and fundraise here.

Tembo capitalizes on the database boom and lands new cash to expand

Tembo takes the popular database, PostgreSQL, and allows it to be easily used in a variety of new ways through an ecosystem of extensions that solve modern engineering pain points. Learn more about the company and fundraise here.

Filter

Nixtla awarded in Fast Company’s Fourth Annual List of the Next Big Things in Tech

Nixtla awarded in Fast Company’s Fourth Annual List of the Next Big Things in Tech

By

,

11.20.2024

Harmonic Announces Series A Funding Round To Accelerate Development of Mathematical Superintelligence

Harmonic Announces Series A Funding Round To Accelerate Development of Mathematical Superintelligence

By

,

9.23.2024

Tembo capitalizes on the database boom and lands new cash to expand

Tembo capitalizes on the database boom and lands new cash to expand

By

,

7.8.2024

Hacking Postgres: DJ Patil and Ray Lane Interview, GreatPoint Ventures -- YouTube

Hacking Postgres: DJ Patil and Ray Lane Interview, GreatPoint Ventures -- YouTube

By

,

7.3.2024

Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseases

Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseases

By

,

4.22.2024

Recogni Raises $102 Million to Advance Next Generation AI Inference System for Generative AI and Intelligent Autonomy

Recogni Raises $102 Million to Advance Next Generation AI Inference System for Generative AI and Intelligent Autonomy

By

,

2.20.2024

Datalogz Secures $5 Million Funding Led by GreatPoint Ventures, Unveiling Their Groundbreaking Solution to End Business Intelligence (BI) Sprawl Across Fortune 500 Enterprises

Datalogz Secures $5 Million Funding Led by GreatPoint Ventures, Unveiling Their Groundbreaking Solution to End Business Intelligence (BI) Sprawl Across Fortune 500 Enterprises

By

,

12.14.2023

Featureform raises $5.5M to bring order to feature management ‘chaos’

Featureform raises $5.5M to bring order to feature management ‘chaos’

By

,

12.13.2023

Shakudo announces $7.2M USD of funding led by GreatPoint Ventures

Shakudo announces $7.2M USD of funding led by GreatPoint Ventures

By

,

7.5.2023

Truvian Sciences Receives FDA Emergency Use Authorization for Easy Check COVID-19 IgM/IgG™ Test

By

,

7.29.2020

Sidecar Health Raises $20 Million to Provide Transparency and Consumer Choice to Health Insurance

By

,

7.23.2020

Activ Surgical™ Raises $15 Million led by ARTIS Ventures to Advance Autonomous and Collaborative Surgery

By

,

7.16.2020

Even Financial Achieves SOC 2 Type I Compliance

By

,

7.15.2020

Glympse Bio Announces $46.7 Million Series B Financing

By

,

7.15.2020

Activ Surgical Appoints Paul Meister to Board of Directors

By

,

7.8.2020

K2 Cyber Security Partners with GuardSight to Secure Critical Web Applications and Container Workloads

By

,

7.8.2020

‍Pharmacy and Healthcare Professionals Nationwide Recognize Patient Safety Benefits of New Consensus Vancomycin Dosing Guidelines, But Fewer than One in Three Plan to Adopt Them

By

,

7.8.2020

Activ Surgical Joins Qualcomm Smart Cities Accelerator Program

By

,

6.30.2020

With echoes of Theranos, Truvian Sciences revives the dream of low-cost, accessible blood tests

By

TechCrunch

,

11.20.2019

A Clear Solution to Supply Chain’s Biggest Problem

A Clear Solution to Supply Chain’s Biggest Problem

A few words about GreatPoint Ventures’ investment in KlearNow

By

Earnest Sweat

,

6.10.2020

New Normal: An inspirational talk with Ray Lane

New Normal: An inspirational talk with Ray Lane

By

Vinnie Mirchandani

,

5.3.2020

Why is there so much bullshit?

Why is there so much bullshit?

By

Mike McCormick

,

8.31.2019

© 2023 GreatPoint Ventures

“Make no little plans; they have no magic to stir men's blood and probably themselves will not be realized. Make big plans; aim high in hope and work.”

— Daniel Hudson Burnham